156 related articles for article (PubMed ID: 23959001)
1. The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons.
Romano A; Cassano T; Tempesta B; Cianci S; Dipasquale P; Coccurello R; Cuomo V; Gaetani S
Peptides; 2013 Nov; 49():21-6. PubMed ID: 23959001
[TBL] [Abstract][Full Text] [Related]
2. Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide.
Romano A; Potes CS; Tempesta B; Cassano T; Cuomo V; Lutz T; Gaetani S
Am J Physiol Endocrinol Metab; 2013 Nov; 305(10):E1266-73. PubMed ID: 24064338
[TBL] [Abstract][Full Text] [Related]
3. High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide.
Romano A; Karimian Azari E; Tempesta B; Mansouri A; Micioni Di Bonaventura MV; Ramachandran D; Lutz TA; Bedse G; Langhans W; Gaetani S
Physiol Behav; 2014 Sep; 136():55-62. PubMed ID: 24802360
[TBL] [Abstract][Full Text] [Related]
4. Role of the area postrema in the hypophagic effects of oleoylethanolamide.
Romano A; Gallelli CA; Koczwara JB; Braegger FE; Vitalone A; Falchi M; Micioni Di Bonaventura MV; Cifani C; Cassano T; Lutz TA; Gaetani S
Pharmacol Res; 2017 Aug; 122():20-34. PubMed ID: 28535974
[TBL] [Abstract][Full Text] [Related]
5. The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin.
Gaetani S; Fu J; Cassano T; Dipasquale P; Romano A; Righetti L; Cianci S; Laconca L; Giannini E; Scaccianoce S; Mairesse J; Cuomo V; Piomelli D
J Neurosci; 2010 Jun; 30(24):8096-101. PubMed ID: 20554860
[TBL] [Abstract][Full Text] [Related]
6. The hypophagic factor oleoylethanolamide differentially increases c-fos expression in appetite regulating centres in the brain of wild type and histamine deficient mice.
Umehara H; Fabbri R; Provensi G; Passani MB
Pharmacol Res; 2016 Nov; 113(Pt A):100-107. PubMed ID: 27543461
[TBL] [Abstract][Full Text] [Related]
7. Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake.
Provensi G; Coccurello R; Umehara H; Munari L; Giacovazzo G; Galeotti N; Nosi D; Gaetani S; Romano A; Moles A; Blandina P; Passani MB
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11527-32. PubMed ID: 25049422
[TBL] [Abstract][Full Text] [Related]
8. Attenuated hypothalamic responses to α-melanocyte stimulating hormone during pregnancy in the rat.
Ladyman SR; Augustine RA; Scherf E; Phillipps HR; Brown CH; Grattan DR
J Physiol; 2016 Feb; 594(4):1087-101. PubMed ID: 26613967
[TBL] [Abstract][Full Text] [Related]
9. Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour.
Sihag J; Jones PJH
Obes Rev; 2018 Feb; 19(2):178-197. PubMed ID: 29124885
[TBL] [Abstract][Full Text] [Related]
10. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
11. The lipid messenger OEA links dietary fat intake to satiety.
Schwartz GJ; Fu J; Astarita G; Li X; Gaetani S; Campolongo P; Cuomo V; Piomelli D
Cell Metab; 2008 Oct; 8(4):281-288. PubMed ID: 18840358
[TBL] [Abstract][Full Text] [Related]
12. Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation.
Soria-Gómez E; Guzmán K; Pech-Rueda O; Montes-Rodríguez CJ; Cisneros M; Prospéro-García O
Pharmacol Res; 2010 May; 61(5):379-84. PubMed ID: 20100574
[TBL] [Abstract][Full Text] [Related]
13. Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide.
Azari EK; Ramachandran D; Weibel S; Arnold M; Romano A; Gaetani S; Langhans W; Mansouri A
Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(2):R167-78. PubMed ID: 24829501
[TBL] [Abstract][Full Text] [Related]
14. Regional c-Fos expression induced by peripheral oxytocin administration is prevented by the vasopressin 1A receptor antagonist SR49059.
Hicks C; Ramos L; Dampney B; Baracz SJ; McGregor IS; Hunt GE
Brain Res Bull; 2016 Oct; 127():208-218. PubMed ID: 27725169
[TBL] [Abstract][Full Text] [Related]
15. Brain molecules and appetite: the case of oleoylethanolamide.
Sarro-Ramírez A; Sánchez-López D; Tejeda-Padrón A; Frías C; Zaldívar-Rae J; Murillo-Rodríguez E
Cent Nerv Syst Agents Med Chem; 2013 Mar; 13(1):88-91. PubMed ID: 23464987
[TBL] [Abstract][Full Text] [Related]
16. Oleoylethanolamide: effects on hypothalamic transmitters and gut peptides regulating food intake.
Serrano A; Pavón FJ; Tovar S; Casanueva F; Señarís R; Diéguez C; de Fonseca FR
Neuropharmacology; 2011 Mar; 60(4):593-601. PubMed ID: 21172362
[TBL] [Abstract][Full Text] [Related]
17. Histamine stimulates c-fos expression in hypothalamic vasopressin-, oxytocin-, and corticotropin-releasing hormone-containing neurons.
Kjaer A; Larsen PJ; Knigge U; Møller M; Warberg J
Endocrinology; 1994 Jan; 134(1):482-91. PubMed ID: 8275963
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity.
Tutunchi H; Saghafi-Asl M; Ostadrahimi A
Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):543-552. PubMed ID: 31868943
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide S Activates Paraventricular Oxytocin Neurons to Induce Anxiolysis.
Grund T; Goyon S; Li Y; Eliava M; Liu H; Charlet A; Grinevich V; Neumann ID
J Neurosci; 2017 Dec; 37(50):12214-12225. PubMed ID: 29118105
[TBL] [Abstract][Full Text] [Related]
20. Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry.
Kiss A; Bundzikova J; Pirnik Z; Mikkelsen JD
J Neurosci Res; 2010 Feb; 88(3):677-85. PubMed ID: 19774673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
